What is Onabet sd used for in the treatment of seborrheic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onabet SD: Indications and Use

Onabet SD (sertaconazole) is used for the topical treatment of seborrheic dermatitis, functioning as an antifungal agent that targets Malassezia yeast while providing anti-inflammatory effects to control the erythema, scaling, and pruritus characteristic of this chronic inflammatory skin condition.

Primary Indication

Onabet SD is specifically formulated for seborrheic dermatitis treatment, addressing the two key pathogenic mechanisms: Malassezia yeast proliferation and inflammatory response 1, 2, 3. The condition manifests as erythematous patches with greasy, yellow scales typically affecting seborrheic areas including the scalp, face, ears, chest, and groin 3, 4.

Treatment Approach Based on Location

Facial Seborrheic Dermatitis

  • Apply ketoconazole 2% cream (or equivalent antifungal like sertaconazole) twice daily to affected facial areas, combining antifungal action against Malassezia with anti-inflammatory properties 5, 6
  • Treatment duration should be four weeks or until clinical clearing 6
  • Avoid alcohol-containing preparations on the face as they significantly worsen dryness and trigger flares 1, 5

Scalp Involvement

  • Use shampoo, gel, solution, or foam formulations rather than creams for scalp application, as hair makes traditional formulations messy and difficult to use 1
  • Apply treatment not more than twice daily for scalp involvement 1

Essential Concurrent Supportive Measures

Skin Care Fundamentals

  • Use mild, pH-neutral (pH 5) non-soap cleansers or dispersible creams as soap substitutes to preserve the skin's natural lipid barrier 1, 5
  • Apply fragrance-free, non-greasy moisturizers containing urea or glycerin immediately after bathing to damp skin 1, 5
  • Use lukewarm water for cleansing; avoid hot water which worsens symptoms 1, 5

Products to Avoid

  • Never use greasy or occlusive creams on affected areas as they worsen folliculitis and inhibit healing 1, 5
  • Avoid products containing neomycin, bacitracin, or fragrances due to high sensitization rates (13-30% with neomycin) 1
  • Do not use topical acne medications or retinoids as they cause excessive drying and irritation 5

Adjunctive Anti-Inflammatory Treatment

Short-Term Corticosteroid Use

  • For significant erythema and inflammation, add low-potency topical corticosteroids (hydrocortisone 1% or prednicarbate 0.02%) 1
  • Limit use to 2-4 weeks maximum, especially on facial skin, due to risks of skin atrophy, telangiectasia, and tachyphylaxis 1, 5
  • Avoid prolonged continuous use on the face beyond this timeframe 1

Alternative for Eyelid Involvement

  • For eyelid margins, tacrolimus 0.03% ointment is the preferred non-steroidal option if ketoconazole is insufficient, as it can be safely used where corticosteroids carry higher risks 5

Monitoring for Complications

Secondary Infections

  • Watch for increased crusting, weeping, or pustules suggesting Staphylococcus aureus superinfection, which requires oral flucloxacillin 1, 5
  • Look for grouped vesicles or punched-out erosions indicating herpes simplex superinfection, requiring immediate oral acyclovir 1, 5

When to Refer to Dermatology

Referral is indicated for 1:

  • Diagnostic uncertainty or atypical presentation
  • Failure to respond after 4 weeks of appropriate first-line therapy
  • Need for second-line treatments
  • Suspected alternative diagnoses (psoriasis, atopic dermatitis, contact dermatitis)
  • Recurrent severe flares despite optimal maintenance therapy

Critical Pitfalls to Avoid

  • Undertreatment due to fear of corticosteroid side effects leads to inadequate disease control; use appropriate potency for adequate duration, then taper 1
  • Do not confuse persistent mild itching with treatment failure, as inflammation can persist for days after yeast elimination 1
  • Distinguish seborrheic dermatitis from psoriasis (look for well-demarcated, indurated plaques with thick silvery scale) and atopic dermatitis (more intense pruritus, lichenification, flexural involvement) which require different treatment approaches 1, 5

References

Guideline

Treatment Options for Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treatment of seborrheic dermatitis: a comprehensive review.

The Journal of dermatological treatment, 2019

Research

Unmet needs for patients with seborrheic dermatitis.

Journal of the American Academy of Dermatology, 2024

Research

Seborrheic Dermatitis: Diagnosis and Treatment.

American family physician, 2025

Guideline

Treatment of Facial Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.